title: Chemotherapy for metastatic non-small-cell lung cancer. A case report.
abstract: The role of chemotherapy for patients with metastatic non-small-cell lung carcinoma (NSCCL) is controversial. A patient with intrathoracic metastatic NSCCL, who was treated by moderate dose cisplatin combination chemotherapy and who remained clinically free of disease more than 5 years after presentation, is described. This treatment has not previously been reported. A trial of moderate-dose cisplatin combination chemotherapy in selected patients with good performance status seems justified.
authors.affiliation: Department of Radiotherapy, University of Cape Town.
authors.forename: R P
authors.initials: RP
authors.lastname: Abratt
authors.forename: P A
authors.initials: PA
authors.lastname: Willcox
authors.forename: E
authors.initials: E
authors.lastname: Bolding
authors.forename: R H
authors.initials: RH
authors.lastname: Hewitson
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis
chemical_list: D005047:Etoposide; D002945:Cisplatin